Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, and Lower Extremity Biomechanics and Pathologies.
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematomas—a German Nationwide Multi-center Study On 718 Embolizations
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO <i>resect</i> group
The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter <i>SUBAROMA</i> study
Evolutionary trajectories of small cell lung cancer under therapy
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO <i>resect</i> group
Benchmarking palliative care practices in neurooncology: a german perspective
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO <i>resect</i> group
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (<i>low-grade appearance</i>): a report of the RANO <i>resect</i> group
DistSNE: Distributed computing and online visualization of DNA methylation‐based central nervous system tumor classification
The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting
The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy
Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment
Brain metastases from esophageal cancer
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial